Maturity Onset Diabetes of the Young
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Maturity Onset Diabetes of the Young

What is the definition of Maturity Onset Diabetes of the Young?
Maturity-onset diabetes of the young (MODY) is a form of diabetes that is characterized by an early onset diabetes. MODY represents about 2% of all diabetes cases and is commonly misdiagnosed as type 1 or type 2 diabetes mellitus. It is due to a primary defect in pancreatic beta cell function. It is inherited in an autosomal dominant pattern.
What are the alternative names for Maturity Onset Diabetes of the Young?
  • Maturity-onset diabetes of the young
  • MODY
  • Mason type diabetes
Who are the top Maturity Onset Diabetes of the Young Local Doctors?
Elite in Maturity Onset Diabetes of the Young
Endocrinology
Elite in Maturity Onset Diabetes of the Young
Endocrinology
Referral required

UNC Hospitals Outpatient Center At Eastowne

100 Eastowne Dr, 
Chapel Hill, NC 
Languages Spoken:
English
Offers Telehealth

John Buse is an Endocrinologist practicing medicine in Chapel Hill, North Carolina. Dr. Buse is rated as an Elite provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Low Blood Sugar, Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Islet Cell Transplantation.

Elite in Maturity Onset Diabetes of the Young
Elite in Maturity Onset Diabetes of the Young
Referral required

Park Nicollet Specialty Center St. Louis Park 3800 Building

3800 Park, 
Nicollet, MN 
Languages Spoken:
English

I am a research clinician at International Diabetes Center (IDC). I work with patients participating in research studies related to type 1 and type 2 diabetes and new diabetes technology. For more information about the many studies offered through IDC, please call 952-993-3500. Being involved in diabetes research can help individuals better manage their diabetes or may help the next generation of people with diabetes. As Executive Director of the IDC, I also participate in training professionals in the US and internationally and publishing diabetes educational materials for patients and professionals. Translating new research findings into improvements in diabetes care is my major professional focus. We are finding that the best approach to improve care is by working as a team and to focus on the needs of each patient. My outreach diabetes clinic in Willmar Minnesota keeps me in clinical practice. My two granddaughters keep me active, amazed and inspired. Dr. Bergenstal is rated as an Elite provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Low Blood Sugar, Type 1 Diabetes (T1D), and Maturity Onset Diabetes of the Young. Dr. Bergenstal is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine-Endocrin,Diabetes&Metabolism.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Maturity Onset Diabetes of the Young
Endocrinology
Distinguished in Maturity Onset Diabetes of the Young
Endocrinology
Referral required

Ballad Health Medical Associates Diabetes And Endocrinology Center

16000 Johnston Memorial Drive, Suite 112, 
Abingdon, VA 
Languages Spoken:
English

Matthew Beasey is an Endocrinologist practicing medicine in Abingdon, Virginia. Dr. Beasey is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Neuropathy, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D). Dr. Beasey is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

What are the latest Maturity Onset Diabetes of the Young Clinical Trials?
Swiss Diabetes Registry - SwissDiab Study, a Prospective Cohort Study of Patients With Diabetes in Switzerland

Summary: Currently, the estimated number of people with diabetes mellitus is approximately 387 million people worldwide. Due to population growth, urbanization, ageing and the rising prevalence of obesity the numbers of individuals with diabetes is increasing likewise. It has been shown that improving glycemic control is associated with a reduction in late complications of diabetes, such as cardiovascular ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Canagliflozin Targeting Vascular Inflammation: An Ottawa Imaging Study - A Pilot Study

Summary: CANTOR SING is a pilot single center double blinded randomized study. The investigators will compare the effect of canagliflozin (300 mg daily - intervention arm) vs. placebo (control group) on the FDG aortic uptake in patients with stable CAD (over 60 days post-myocardial infarction) after a 6-month period of treatment. The investigators plan to enroll 8 patients in each arm (total sample size: 1...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Maturity Onset Diabetes of the Young?